BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28277314)

  • 1. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.
    Liu C; Du H; Wang C; Belinson JL; Yang B; Zhang W; Tang J; Wu R
    Int J Gynecol Pathol; 2017 May; 36(3):281-288. PubMed ID: 28277314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.
    Hoshikawa S; Sano T; Yoshida T; Ito H; Oyama T; Fukuda T
    Pathol Res Pract; 2010 Dec; 206(12):816-20. PubMed ID: 20965668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
    Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
    Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
    Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
    Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical values of HPV L1 and p16INK4a protein in uterine cervical lesions].
    Song Y; Li Q; Li L; Chen W; Shen GH; Qiao YL; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):352-5. PubMed ID: 22883455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials.
    Mills AM; Paquette C; Castle PE; Stoler MH
    Am J Surg Pathol; 2015 May; 39(5):611-7. PubMed ID: 25602791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
    Gatta LB; Berenzi A; Balzarini P; Dessy E; Angiero F; Alessandri G; Gambino A; Grigolato P; Benetti A
    Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.
    Carozzi F; Cecchini S; Confortini M; Becattini V; Cariaggi MP; Pontenani G; Sani C; Ciatto S
    Cancer; 2006 Apr; 108(2):119-23. PubMed ID: 16411180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker.
    Hilfrich R; Hariri J
    Anal Quant Cytol Histol; 2008 Apr; 30(2):78-82. PubMed ID: 18561743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y; Liu J; Gong L; Sun X; Long W
    Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.
    Xing Y; Wang C; Wu J
    Medicine (Baltimore); 2017 Jun; 96(26):e7302. PubMed ID: 28658133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus DNA, HPV L1 capsid protein and p16
    Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1.
    Choi YS; Kang WD; Kim SM; Choi YD; Nam JH; Park CS; Choi HS
    Int J Gynecol Cancer; 2010 Feb; 20(2):288-93. PubMed ID: 20134272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.